Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bauer

Showing results (1231-1240 of 1,238) with videos related to

Pageof 124
Sort By:
You have reached the last page of results.This site can display upto 1,238 results.
The Journal of Bone and Joint Surgery. American Volume|July 22, 2021
Sequencing of Circulating Microbial Cell-Free DNA Can Identify Pathogens in Periprosthetic Joint InfectionsAdriana P Echeverria, Ian S Cohn, David C Danko, et al.
Der Urologe. Ausg. A|February 11, 2003
[European Association of Urology guidelines on urinary and male genital tract infections]P Schneede, A G Hofstetter, K G Naber, et al.
JCI Insight|June 7, 2019
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosaSu M Lwin, Farhatullah Syed, Wei-Li Di, et al.
Archives of Pathology & Laboratory Medicine|February 15, 2020
Digital Whole Slide Imaging Compared With Light Microscopy for Primary Diagnosis in Surgical PathologyAlexander D Borowsky, Eric F Glassy, William Dean Wallace, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Science Translational Medicine|August 24, 2018
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosaRaymond J Cho, Ludmil B Alexandrov, Nicoline Y den Breems, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 4, 2021
The 2021 Magnonics RoadmapAnjan Barman, Gianluca Gubbiotti, S Ladak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 124

Showing results (1231-1240 of 1,238) with videos related to

Sort By:
Pageof 124
You have reached the last page of results.This site can display upto 1,238 results.
The Journal of Bone and Joint Surgery. American Volume|July 22, 2021
Sequencing of Circulating Microbial Cell-Free DNA Can Identify Pathogens in Periprosthetic Joint InfectionsAdriana P Echeverria, Ian S Cohn, David C Danko, et al.
Der Urologe. Ausg. A|February 11, 2003
[European Association of Urology guidelines on urinary and male genital tract infections]P Schneede, A G Hofstetter, K G Naber, et al.
JCI Insight|June 7, 2019
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosaSu M Lwin, Farhatullah Syed, Wei-Li Di, et al.
Archives of Pathology & Laboratory Medicine|February 15, 2020
Digital Whole Slide Imaging Compared With Light Microscopy for Primary Diagnosis in Surgical PathologyAlexander D Borowsky, Eric F Glassy, William Dean Wallace, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Science Translational Medicine|August 24, 2018
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosaRaymond J Cho, Ludmil B Alexandrov, Nicoline Y den Breems, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 4, 2021
The 2021 Magnonics RoadmapAnjan Barman, Gianluca Gubbiotti, S Ladak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 124